Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) ELISA Kits (CDKN2D)
Auf finden Sie aktuell 0 Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) ELISA Kits von unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen CDKN2D Antikörper (73) und CDKN2D Proteine (9) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 89 CDKN2D Produkte verfügbar.
ank2, CDKN2D, INK4d, p19, p19-INK4D, p19INK4d
list all ELISA KIts Gen GeneID UniProt
Human CDKN2D CDKN2D 1032 P55273
Maus CDKN2D CDKN2D 12581 Q60773
Ratte CDKN2D CDKN2D 494444  

Weitere Synonyme anzeigen

Weitere ELISA Kits für CDKN2D Interaktionspartner

Human Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) Interaktionspartner

  1. We unexpectedly found that p19INK4d plays an important role in human terminal erythropoiesis

  2. p19(INK4D) is one of the key mediators of miR (zeige MLXIP ELISA Kits)-125b activity during the onset of megakaryocyte polyploidization.

  3. p19 may play an important role in the ototoxic effects of cisplatin and is probably involved in the pathogenesis of hearing loss.

  4. MiR (zeige MLXIP ELISA Kits)-451 inhibited the proliferation of esophageal squamous cell carcinoma cells by targeting CDKN2D and MAP3K1 (zeige MAP3K1 ELISA Kits) expression.

  5. Data indicate that upon oxidative DNA damage, cyclin-dependent kinase (zeige CDK1 ELISA Kits) inhibitor p19INK4d strongly binds to and relaxes chromatin.

  6. CDKN2D repression by PML (zeige PML ELISA Kits)/RARalpha (zeige RARA ELISA Kits) disrupts both cell proliferation and differentiation in the pathogenesis of acute promyelocytic leukemia (zeige PML ELISA Kits).

  7. p19-INK4d inhibits neuroblastoma (zeige ARHGEF16 ELISA Kits) cell growth, induces differentiation and is hypermethylated and downregulated in MYCN (zeige MYCN ELISA Kits)-amplified neuroblastomas.

  8. CDKN2D-WDFY2 (zeige ZFYVE22 ELISA Kits) fusion could be an important molecular signature for understanding and classifying sub-lineages among heterogeneous high-grade serous ovarian carcinomas.

  9. Mutations in CDKN2D is associated with sporadic parathyroid adenoma.

  10. P19(INK4d) expression is a poor prognostic factor in ovarian cancer patients.

Mouse (Murine) Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) Interaktionspartner

  1. TWIST1 (zeige TWIST1 ELISA Kits)-E protein heterodimeric complexes may thus constitute the main active forms of TWIST1 (zeige TWIST1 ELISA Kits) with regard to senescence inhibition over the time course of breast tumorigenesis.

  2. Rescue from early-onset hearing loss in a mouse model lacking the cyclin-dependent kinase (zeige CDK1 ELISA Kits) inhibitor p19Ink4d.

  3. p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging

  4. Cdk4 (zeige CDK4 ELISA Kits) and Cdk6 (zeige CDK6 ELISA Kits) cooperate in hematopoietic tumor development and suggest a role for Cdk6 (zeige CDK6 ELISA Kits) in sequestering INK4 proteins away from Cdk4 (zeige CDK4 ELISA Kits).

  5. Deletion of p19(Ink4d) (p19), a cyclin-dependent kinase (zeige CDK1 ELISA Kits) CDK (zeige CDK4 ELISA Kits) inhibitor gene, in mice results in spontaneous development of tumors in multiple organs and tissues.

  6. We propose that p19INK4d participates in the cellular mechanisms that trigger senescence by contributing to chromatin compaction

  7. CDK5 (zeige CDK5 ELISA Kits)-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions.

  8. an asymmetrical distribution pattern for Cdkn2d transcripts in 2-cell embryos.

  9. Ectopic expression of RUVBL2 decreases the levels of ARF, whereas knockdown of RUVBL2 results in a marked increase in ARF levels. In addition, RUVBL2 down-regulates the levels of p53 in an ARF-dependent manner.

  10. DeltaNp63alpha has oncogenic activity and its overexpression in human squamous cell carcinomas contributes to the malignant phenotype, and implicate its ability to regulate p16(ink4a)/p19(arf) in the process.

CDKN2D Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to form a stable complex with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase. The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, as well as spermatogenesis. Two alternatively spliced variants of this gene, which encode an identical protein, have been reported.

Alternative names and synonyms associated with CDKN2D

  • cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (cdkn2d) Elisa Kit
  • cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (CDKN2D) Elisa Kit
  • Cyclin-dependent kinase 4 inhibitor D (cdn2d) Elisa Kit
  • cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (Cdkn2d) Elisa Kit
  • similar to cyclin-dependent kinase inhibitor 2D (Cdkn2d) Elisa Kit
  • ank2 Elisa Kit
  • CDKN2D Elisa Kit
  • INK4d Elisa Kit
  • p19 Elisa Kit
  • p19-INK4D Elisa Kit
  • p19INK4d Elisa Kit

Bezeichner auf Proteinebene für CDKN2D

cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) , cyclin-dependent kinase 4 inhibitor D , Cyclin-dependent kinase 4 inhibitor D , CDK inhibitor p19INK4d , cell cycle inhibitor, Nur77 associating protein , cyclin-dependent kinase 4 inhibitor D p19 , inhibitor of cyclin-dependent kinase 4d , p19-INK4d

446719 Xenopus laevis
611216 Canis lupus familiaris
713172 Macaca mulatta
745942 Pan troglodytes
780300 Xenopus (Silurana) tropicalis
100196083 Salmo salar
1032 Homo sapiens
12581 Mus musculus
510244 Bos taurus
494444 Rattus norvegicus
Haben Sie etwas anderes gesucht?